Sichuan Biokin Pharmaceutical Co.,Ltd. (SHA:688506)
China flag China · Delayed Price · Currency is CNY
233.00
+7.75 (3.44%)
Feb 28, 2025, 4:00 PM CST

SHA:688506 Ratios and Metrics

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2018 - 2015
Period Ending
Feb '25 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2018 - 2015
Market Capitalization
86,21556,100----
Upgrade
Enterprise Value
82,78956,019----
Upgrade
Last Close Price
215.00139.90----
Upgrade
PS Ratio
14.5999.84----
Upgrade
PB Ratio
20.32369.39----
Upgrade
P/TBV Ratio
18.62452.87----
Upgrade
EV/Sales Ratio
14.2299.70----
Upgrade
Debt / Equity Ratio
0.374.530.590.860.330.46
Upgrade
Debt / EBITDA Ratio
0.38---5.6824.32
Upgrade
Debt / FCF Ratio
0.36---2.3828.05
Upgrade
Asset Turnover
1.400.330.480.800.95-
Upgrade
Inventory Turnover
1.812.002.592.752.82-
Upgrade
Quick Ratio
2.460.521.730.620.890.91
Upgrade
Current Ratio
2.970.741.930.901.071.07
Upgrade
Return on Equity (ROE)
163.15%-143.77%-44.62%-25.51%8.62%-
Upgrade
Return on Assets (ROA)
60.19%-28.74%-14.01%-10.00%-1.34%-
Upgrade
Return on Capital (ROIC)
77.02%-42.30%-19.63%-16.33%-2.33%-
Upgrade
Return on Capital Employed (ROCE)
82.40%-----
Upgrade
Earnings Yield
4.18%-1.39%----
Upgrade
FCF Yield
5.47%-1.24%----
Upgrade
Payout Ratio
0.82%---26.28%389.13%
Upgrade
Buyback Yield / Dilution
-1.81%-10.56%-1.38%-3.64%10.86%-276.33%
Upgrade
Total Shareholder Return
-1.81%-10.56%-1.38%-3.64%10.86%-276.33%
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.